Earn CME: https://www.naccme.com/program/19-lm-11 In this webcast from the ‘Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Drs. Bruce D. Cheson and Richard I. Fisher debate whether chemotherapy still has a major role in the treatment of follicular lymphoma. © 2019 Imedex, an HMP Company
Follicular Lymphoma Debate: Chemotherapy no Longer Has a Major Role in the Treatment
